SenzaGen AB: GARD going stronger and subsidiary enters new phase
Message from the CEO"2024 was yet another strong year for SenzaGen with record growth for our core business GARD®, with sales increasing by 53% to nearly SEK 40 million. The Group's total revenue incr ...
C&EN27 天
Dual Pathways of Photorelease Carbon Monoxide via Photosensitization for Tumor Treatment
State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Centre for New Organic Matter, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Research Centre for Analytical ...